Analysis of Patients Admitted for Asthma Exacerbation in a Tertiary Hospital in Spain

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Jul 25

PMID 39050304

Authors

Eusebi Chiner

Clara Machetti

Ignacio Boira

Violeta Esteban

Carmen Castello Faus

Anastasiya Torba Kordyukova

Affiliations

Soon will be listed here.

Abstract

Objectives: To analyze the characteristics of adult patients admitted for asthma exacerbation and determine optimization, treatment adherence, and follow-up in clinics.

Methods: Patients ≥ 18 years old admitted from May 2021 to June 2023 with a primary diagnosis of asthma exacerbation were included. Patients with a secondary diagnosis of asthma exacerbation and those without a confirmed diagnosis were excluded.

Results: A total of 186 patients were analyzed, 63% were female, with a mean age of 49 ± 34 years, mean body mass index (BMI) of 26.4 ± 5 kg/m2, mean immunoglobulin E level of 132 ± 235 IU/mL (range: 25-2041), mean eosinophils count of 180 ± 443, and length of stay of 8.6 ± 5 days. Comparing patients with one admission to those with multiple admissions, differences were observed in age (39 ± 15 vs. 58 ± 20, p < 0.0001), BMI (25.2 ± 3 vs. 27.4 ± 4, p < 0.0003), comorbidity (15% vs. 60%, p < 0.0001), and length of stay (4.5 ± 2 vs. 11 ± 3, p < 0.0001). Of the patients, 15% had undiagnosed asthma, 28% had known asthma without maintenance therapy, 23% were managed by primary care, and 34% were followed by pneumology. The mean Test of Adherence to Inhalers (TAI) score was 42.5 ± 8 points, with 70% showing erratic non-adherence, 46% showing deliberate non-adherence, and 21% showing unconscious non-adherence.

Conclusions: The young population represents a significant percentage of admissions for asthma exacerbation due to poor follow-up in pulmonology clinics, inadequate treatment optimization, and low adherence. This study adds that it is necessary to improve the approach to asthma in primary care to optimize treatment, reduce under-diagnosis, and avoid hospital admissions.

References

Emerman C . Relapse following treatment of acute asthma in the emergency department. J Asthma. 2001; 37(8):701-8. DOI: 10.3109/02770900009087309. View

Shaw D, Gaynor C, Fogarty A . Changes in asthma mortality in England and Wales since 2001. Thorax. 2019; 74(12):1174-1175. DOI: 10.1136/thoraxjnl-2019-213350. View

Garcia-Rio F, Calle M, Burgos F, Casan P, Campo F, Galdiz J . Spirometry. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Arch Bronconeumol. 2013; 49(9):388-401. DOI: 10.1016/j.arbres.2013.04.001. View

de Miguel-Diez J, Jimenez-Garcia R, Hernandez-Barrera V, Lopez de Andres A, Villa-Asensi J, Plaza V . National trends in hospital admissions for asthma exacerbations among pediatric and young adult population in Spain (2002-2010). Respir Med. 2014; 108(7):983-91. DOI: 10.1016/j.rmed.2014.04.008. View

Losappio L, Heffler E, Carpentiere R, Fornero M, Cannito C, Guerrera F . "Characteristics of patients admitted to emergency department for asthma attack: a real-LIFE study". BMC Pulm Med. 2019; 19(1):107. PMC: 6580601. DOI: 10.1186/s12890-019-0869-8. View

Plaza V, Fernandez-Rodriguez C, Melero C, Cosio B, Entrenas L, Perez de Llano L . Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients. J Aerosol Med Pulm Drug Deliv. 2015; 29(2):142-52. PMC: 4841905. DOI: 10.1089/jamp.2015.1212. View

Ribo P, Molina J, Calle M, Maiz L, Campo C, Rytila P . Prevalence of modifiable factors limiting treatment efficacy of poorly controlled asthma patients: EFIMERA observational study. NPJ Prim Care Respir Med. 2020; 30(1):33. PMC: 7395116. DOI: 10.1038/s41533-020-00189-6. View

Dominguez-Ortega J, Luna-Porta J, Olaguibel J, Barranco P, Arismendi E, Barroso B . Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity. J Investig Allergol Clin Immunol. 2022; 33(4):281-288. DOI: 10.18176/jiaci.0816. View

Gonzalez-Barcala F, Calvo-Alvarez U, Garcia-Sanz M, Bourdin A, Pose-Reino A, Carreira J . Characteristics and prognosis of near-fatal asthma exacerbations. Am J Med Sci. 2015; 350(2):98-102. DOI: 10.1097/MAJ.0000000000000518. View

10.

Quint J, Arnetorp S, Kocks J, Kupczyk M, Nuevo J, Plaza V . Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America. J Allergy Clin Immunol Pract. 2022; 10(9):2297-2309.e10. DOI: 10.1016/j.jaip.2022.02.047. View

11.

Martinez-Moragon E, Serra-Batlles J, De Diego A, Palop M, Casan P, Rubio-Terres C . [Economic cost of treating the patient with asthma in Spain: the AsmaCost study]. Arch Bronconeumol. 2009; 45(10):481-6. DOI: 10.1016/j.arbres.2009.04.006. View

12.

Gonzalez-Barcala F, Calvo-Alvarez U, Salgado-Castro F, Facal D, Garcia-Sanz M, Munoz X . Asthma exacerbations: factors related to longer hospital stay. Acta Clin Belg. 2017; 72(6):379-384. DOI: 10.1080/17843286.2017.1295524. View

13.

Azzi E, Kritikos V, Peters M, Price D, Srour P, Cvetkovski B . Understanding reliever overuse in patients purchasing over-the-counter short-acting beta agonists: an Australian community pharmacy-based survey. BMJ Open. 2019; 9(8):e028995. PMC: 6701672. DOI: 10.1136/bmjopen-2019-028995. View

14.

DiMango E, Rogers L, Reibman J, Gerald L, Brown M, Sugar E . Risk Factors for Asthma Exacerbation and Treatment Failure in Adults and Adolescents with Well-controlled Asthma during Continuation and Step-Down Therapy. Ann Am Thorac Soc. 2018; 15(8):955-961. DOI: 10.1513/AnnalsATS.201711-886OC. View

15.

Chiner E, Hernandez C, Blanco-Aparicio M, Funenga-Fitas E, Jimenez-Ruiz C . Patient perspectives of the influence of severe and non-severe asthma on their quality of life: A national survey of asthma patients in Spain. Clin Respir J. 2021; 16(2):130-141. PMC: 9060022. DOI: 10.1111/crj.13461. View

16.

Plaza Moral V, Alobid I, Alvarez Rodriguez C, Blanco Aparicio M, Ferreira J, Garcia G . GEMA 5.3. Spanish Guideline on the Management of Asthma. Open Respir Arch. 2023; 5(4):100277. PMC: 10598226. DOI: 10.1016/j.opresp.2023.100277. View

17.

Altzibar J, Tamayo-Uria I, De Castro V, Aginagalde X, Albizu M, Lertxundi A . Epidemiology of asthma exacerbations and their relation with environmental factors in the Basque Country. Clin Exp Allergy. 2014; 45(6):1099-108. DOI: 10.1111/cea.12419. View

18.

Bloom C, Walker S, Quint J . Inadequate specialist care referrals for high-risk asthma patients in the UK: an adult population-based cohort 2006-2017. J Asthma. 2019; 58(1):19-25. DOI: 10.1080/02770903.2019.1672723. View

19.

Ebmeier S, Thayabaran D, Braithwaite I, Benamara C, Weatherall M, Beasley R . Trends in international asthma mortality: analysis of data from the WHO Mortality Database from 46 countries (1993-2012). Lancet. 2017; 390(10098):935-945. DOI: 10.1016/S0140-6736(17)31448-4. View

20.

Osborne M, Vollmer W, Linton K, Buist A . Characteristics of patients with asthma within a large HMO: a comparison by age and gender. Am J Respir Crit Care Med. 1998; 157(1):123-8. DOI: 10.1164/ajrccm.157.1.9612063. View